Difference between revisions of "Microphthalmia transcription factor"
Jump to navigation
Jump to search
(teak) |
|||
| Line 2: | Line 2: | ||
==General== | ==General== | ||
MITF is a in the ''microphthalmia'' (abbreviated ''MiT'') subfamily of transcription factors that also inclues TFE3, TFEB, TFEC.<ref>{{cite journal | | MITF is a in the ''microphthalmia'' (abbreviated ''MiT'') subfamily of transcription factors that also inclues TFE3, TFEB, TFEC.<ref>{{cite journal |authors=Xie L, Zhang Y, Wu CL |title=Microphthalmia family of transcription factors associated renal cell carcinoma |journal=Asian J Urol |volume=6 |issue=4 |pages=312–320 |date=October 2019 |pmid=31768316 |pmc=6872788 |doi=10.1016/j.ajur.2019.04.003 |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 15:30, 5 November 2021
Microphthalmia transcription factor, abbreviated MITF, is a common immunostain in the diagnosis of malignant melanoma.
General
MITF is a in the microphthalmia (abbreviated MiT) subfamily of transcription factors that also inclues TFE3, TFEB, TFEC.[1]
References
- ↑ Xie L, Zhang Y, Wu CL (October 2019). "Microphthalmia family of transcription factors associated renal cell carcinoma". Asian J Urol 6 (4): 312–320. doi:10.1016/j.ajur.2019.04.003. PMC 6872788. PMID 31768316. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872788/.